Gain Therapeutics, Inc. (GANX) Operating Lease, Liability USD 2021 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Gain Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2021 to 2024.
Gain Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $382 K, a 38.2% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$382 K	-$236 K	-38.2%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$460 K	-$211 K	-31.5%	Dec 31, 2023	10-K	2024-03-26
Q3 2023	$495 K	-$189 K	-27.7%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$566 K	-$195 K	-25.6%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$618 K	-$229 K	-27.1%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$671 K	-$243 K	-26.6%	Dec 31, 2022	10-K	2023-03-23
Q3 2022	$684 K			Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$761 K			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$848 K			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$914 K			Dec 31, 2021	10-K	2022-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.